175 related articles for article (PubMed ID: 25971328)
21. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
[TBL] [Abstract][Full Text] [Related]
22. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
[TBL] [Abstract][Full Text] [Related]
23. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
24. The effect of metformin on mortality following cancer among patients with diabetes.
Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
[TBL] [Abstract][Full Text] [Related]
25. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.
Peairs KS; Barone BB; Snyder CF; Yeh HC; Stein KB; Derr RL; Brancati FL; Wolff AC
J Clin Oncol; 2011 Jan; 29(1):40-6. PubMed ID: 21115865
[TBL] [Abstract][Full Text] [Related]
27. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.
Ganesh A; Randall MD
Br J Clin Pharmacol; 2022 Jun; 88(6):2642-2656. PubMed ID: 35122284
[TBL] [Abstract][Full Text] [Related]
28. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
29. Use of metformin and survival of diabetic women with breast cancer.
Peeters PJ; Bazelier MT; Vestergaard P; Leufkens HG; Schmidt MK; de Vries F; De Bruin ML
Curr Drug Saf; 2013 Nov; 8(5):357-63. PubMed ID: 24215316
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
31. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
[TBL] [Abstract][Full Text] [Related]
32. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
33. Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Li Y; Zhao H; Guo Y; Duan Y; Guo Y; Ding X
Front Endocrinol (Lausanne); 2021; 12():811776. PubMed ID: 35002982
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer.
De Bruijn KM; Arends LR; Hansen BE; Leeflang S; Ruiter R; van Eijck CH
Br J Surg; 2013 Oct; 100(11):1421-9. PubMed ID: 24037561
[TBL] [Abstract][Full Text] [Related]
35. Association between metformin therapy and mortality after breast cancer: a population-based study.
Lega IC; Austin PC; Gruneir A; Goodwin PJ; Rochon PA; Lipscombe LL
Diabetes Care; 2013 Oct; 36(10):3018-26. PubMed ID: 23633525
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study.
Lin TC; Hwang DK; Hsu CC; Peng CH; Wang ML; Chiou SH; Chen SJ
PLoS One; 2017; 12(11):e0188136. PubMed ID: 29136662
[TBL] [Abstract][Full Text] [Related]
37. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
38. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
Fransgaard T; Thygesen LC; Gögenur I
Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
[TBL] [Abstract][Full Text] [Related]
39. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
40. Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies.
Zhang D; Zhao Y; Wang T; Xi Y; Li N; Huang H
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27860198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
